Attendees

NameRolePresent
Wright, Larry NIH/NCI  x
Fragoso, Gilberto NIH/NCI    x

De Coronado, Sherri    

NIH/NCI   x

Safran, Tracy

NIH/NCI [C]x
Ong, Kim L
ISx
Lucas, Jason R
ISx
Bauer, Scott  Mayox
Stancl, Craig
Mayox
Endle,  CoryMayox
Wynne, Robert    NIH/NCI [C]x
Tran, Tin    NIH/NCI [C] x
Carlsen, Brian NIH/NCI [C] 
Wong, Joanne NIH/NCI [C] 

Kuntipuram, Kumar

NIH/NCI [C]x

Action Items

AssignedDescriptionDate IdentifiedDue DateDate CompletedStatus
CoryAdd link to Maven Opts for end users2016.12.21  

Open

Agenda

Sprint Status

 

Current Sprint  Sprint 50 (February 16, 2017 – March 1, 2017)

16X237 Agile Development - Sprint Status#16X237AgileDevelopment-SprintStatus-Sprint50

  • Report writer team may need to test with Java8

DEV Server Configurations

  • Planning and usage discussion

Discussion Points:

  • Dev VM (Mayo) is set up and we confirmed we can log in
  • Dev Blade - Jacob is waiting for the Mayo Dev team to let him know if tomcat 8 will work.

Decision Points:

  • Cory to confirm with Jacob what version of tomcat 8.x NCI is going to run.

6.4.1.3 FINAL build update

  • Creating 6.4.1.3.FINAL

Discussion Points:

Decision Points:

Value Set Loading Enhancements

  • Update

Discussion Points:

Decision Points:

LexEVS Version/Naming Discussion

 

Discussion Points:

  • LexEVS Software Release Versioning
  • Larry suggested if the release has a major impact on the end user (consumers), then we would increment the major version number.
  • If the user created their own instance of LexEVS, then the versioning would affect them more than just being a consumer of the API. 

Decision Points:

  • The team will think about this and discuss again next week.
CTS2 REST API Discussion

Discussion Points:

  • End users are not familiar with the CTS2 model and REST API.
  • This doesn't fit well with end LexEVS users as they are not familiar with the CTS2 model.
  • It was suggested that it may make sense to have a REST API that represents the LexEVS Model.
  • Example scenarios:
    • For a given regime concept, give me the associated drugs. (the user knows the relationship)
    • This was available under caCore.
  • Users of CTS2:
    • Bob Kline (CTL), CTRP, Brian Bazilla
  • Tracy created multiple JIRA issues capturing the issues:
    • LEXEVSCTS2-138-144
      • Most of these issues were possible under caCore data services.
  • Larry suggested looking at the UMLS REST interface

Decision Points:

  • Mayo Dev team will discuss and come up with some possible solutions and report back to the team.

LexEVS Logical Role Relationship

  • Discussion with Kim

Discussion Points:

  •  
  • Kim is questioning the difference between inferred and asserted versions.
  • DEV vs PROD browser - inferred versions for neoplasm are different.

Decision Points:

  • Kim to provide some screen shots/examples of this issue.
LexEVS External Users

Discussion Points:

  • Nothing noted.

Decision Points:

Proposed Backlog Review Items

Discussion Points:

Decision Points:

Team Absences

Mayo Team

  • Cory -
  • Scott -
  • Craig - March 6-13

NCI

  • Tracy
    • March 9-17
  • Rob
    • March 20-24

JIRA Issues

Recent LexEVS Related Bugs and Features (within last week)

Recent CTS2 Service Related Issues (within last week)

6.4 LexEVS Related Issues

6.4 CTS2 Service Related Issues

Project Plan Changes

#DescriptionDue DateResourcesNotesRisksMitigation
 None     
       
       

 Planned Activities

Area of InterestDetails
  
  
  

Risks, Issues, Dependencies

Risks

Opened DateDue DateDescriptionLikelihood (H, M, L)ImpactAssignedStatusMitigation Strategy
         
         

Issues

 #Opened DateDescriptionImpactAssignedStatus
      
      
      

Dependencies

Opened DateDescriptionAssigned
   
   

 

Action Item Backlog

 #AssignedDescriptionDate IdentifiedDue DateDate CompletedStatus